• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Methyl 2-amino-4-fluoro-5-nitrobenzoate (CAS No. 910249-58-0): A Comprehensive Overview

Methyl 2-amino-4-fluoro-5-nitrobenzoate, with the chemical identifier CAS No. 910249-58-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound, characterized by its unique structural and functional attributes, holds promise in various research applications, particularly in the development of novel therapeutic agents.

The molecular structure of methyl 2-amino-4-fluoro-5-nitrobenzoate consists of a benzoate core substituted with amino, fluoro, and nitro functional groups. This arrangement imparts distinct chemical properties that make it a valuable intermediate in synthetic chemistry. The presence of the amino group at the 2-position enhances its reactivity, allowing for further functionalization, while the fluoro and nitro groups contribute to its electronic properties and potential biological activity.

In recent years, there has been a growing interest in exploring the pharmacological potential of fluorinated aromatic compounds. The introduction of fluorine atoms into molecular structures often enhances metabolic stability, bioavailability, and binding affinity to biological targets. Methyl 2-amino-4-fluoro-5-nitrobenzoate exemplifies this trend, as its fluorinated derivative has shown promise in preclinical studies as a modulator of enzyme activity and receptor binding.

One of the most compelling aspects of methyl 2-amino-4-fluoro-5-nitrobenzoate is its utility as a building block in drug discovery. Researchers have leveraged its structural features to design and synthesize novel compounds with enhanced pharmacokinetic profiles. For instance, derivatives of this compound have been investigated for their potential antiviral and anti-inflammatory properties. The nitro group, in particular, serves as a versatile handle for further chemical modifications, enabling the creation of diverse molecular scaffolds.

The synthesis of methyl 2-amino-4-fluoro-5-nitrobenzoate involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and selective fluorination techniques, have been employed to achieve high yields and purity. These synthetic strategies not only highlight the compound's complexity but also underscore the sophistication of modern chemical synthesis.

Recent advancements in computational chemistry have further enhanced the understanding of methyl 2-amino-4-fluoro-5-nitrobenzoate's interactions with biological targets. Molecular modeling studies have revealed that this compound can bind to specific protein receptors with high affinity, suggesting its potential as an inhibitor or activator of enzymatic pathways. Such insights are crucial for designing next-generation drugs with improved therapeutic efficacy and reduced side effects.

The pharmaceutical industry has taken note of these findings, leading to increased investment in fluorinated benzoate derivatives. Companies are actively exploring ways to incorporate compounds like methyl 2-amino-4-fluoro-5-nitrobenzoate into their drug development pipelines. This interest is driven by the compound's unique properties and its potential to address unmet medical needs in various therapeutic areas.

Beyond pharmaceutical applications, methyl 2-amino-4-fluoro-5-nitrobenzoate has found utility in materials science and agrochemical research. Its structural motifs are inspiration for designing advanced materials with tailored electronic properties. Additionally, fluorinated benzoates have been explored as intermediates in the synthesis of crop protection agents, where their stability and reactivity offer significant advantages.

The future prospects for methyl 2-amino-4-fluoro-5-nitrobenzoate are promising, with ongoing research aimed at expanding its applications and understanding its mechanisms of action. Collaborative efforts between academia and industry are expected to drive innovation in this field, leading to the development of new drugs and materials that benefit society.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)